Trialytic
Beta test
Explore
Trial search
Landscape by condition or drug
Targets
Drugs by mechanism — TIGIT, PD-1…
Sponsors
Portfolios and completion rates
Safety
Drugs
FAERS signals, labels, recalls
Devices
MAUDE signals and clearances
Drug classes
Compare molecules within a class
Design
Completion predictor
Will this trial finish?
Protocol benchmarker
Vs. comparable trials
Evidence
Meta-analysis
Pooled effect sizes
Search…
⌘K
Docs
Pro
Home
/
Sponsors
/
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Loading sponsor profile…